MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1

Cancer Biology and Therapy

Volumn 15, Issue 10, 2014, Pages 1340-1349

  Zhou, Jianda ^a   Liu, Rui ^a   Luo, Chengqun ^a   Zhou, Xiao ^b   Xia, Kun ^c   Chen, Xiang ^d   Zhou, Ming ^e   Zou, Qiong ^a   Cao, Peiguo ^a   Cao, Ke ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN CANCER HOSPITAL   (China)

^c Central South   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e BEIJING HOSPITAL   (China)

Author keywords

Cutaneous squamous cell carcinoma; LIMK1; Metastasis; MiR 20a; Proliferation

Indexed keywords

LIM KINASE 1; MESSENGER RNA; MICRORNA 20A; LIM KINASE; LIMK1 PROTEIN, HUMAN; MICRORNA; MIRN20 MICRORNA, HUMAN;

AGED; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMING CELL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MTT ASSAY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CARCINOMA; VERY ELDERLY; WESTERN BLOTTING; CELL MOTION; GENETICS; METABOLISM; PATHOLOGY; SECONDARY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE;

CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; LIM KINASES; MICRORNAS; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84908454406     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.29821     Document Type: Article

References (42)

1. Toll A, Masferrer E, Hernández-Ruiz ME, Ferrandiz-Pulido C, Yébenes M, Jaka A, Tuneu A, Jucglà A, Gimeno J, Baró T, et al. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases. J Dermatol Sci 2013; 72: 93-102; PMID: 23928229; http://dx.doi.org/10.1016/j.jdermsci.2013.07.001
2. JIAO Ya-ning, XIA Li, GE Xin-hong, ZHANG Xiu-juan, LIU Jian-ping, WANG Li-peng, DONG Ling-di, YU Nan, Xiao-ming Z. The Incidence Analysis of Skin Common Tumor from Five Hospitals in Ningxia from 2002 to 2011. The Chinese Journal of Dermatovenereology 2013: 36-8
3. Gao TW, Sun DJ, Li CY, He H, Li Q, Liu YS, Diao QC, Huang GS, Hao F, Zhong BY, et al. [Retrospective analysis of 1905 patients with skin cancer from two general hospitals in western China from 1981 to 2000]. Beijing Da Xue Xue Bao 2004; 36: 469-72; PMID: 15489924
4. Rahimi S. Squamous cell carcinoma of skin: a brief review. Clin Ter 2013; 164: 143-7; PMID: 23698209
5. Brougham ND, Dennett ER, Cameron R, Tan ST. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol 2012; 106: 811-5; PMID: 22592943; http://dx.doi.org/10.1002/jso.23155
6. Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol 2013; 149: 541-7; PMID: 23677079; http://dx.doi.org/10.1001/jamadermatol.2013.2139
7. Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol 2013; 68: 957-66; PMID: 23375456; http://dx.doi.org/10.1016/j.jaad.2012.11.037
8. Song F, Qureshi AA, Giovannucci EL, Fuchs CS, Chen W Y, Stampfer MJ, Han J. Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study. PLoS Med 2013; 10: e1001433; PMID: 23630459; http://dx.doi.org/10.1371/journal.pmed.1001433
9. Johannesdottir SA, Lash TL, Jensen AO, Farkas DK, Olesen AB. Mortality in cancer patients with a history of cutaneous squamous cell carcinoma - a nationwide population-based cohort study. BMC Cancer 2012; 12: 126; PMID: 22458954; http://dx.doi.org/10.1186/1471-2407-12-126
10. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-73; PMID: 15685193; http://dx.doi.org/10.1038/nature03315
11. Kanitz A, Imig J, Dziunycz PJ, Primorac A, Galgano A, Hofbauer GF, Gerber AP, Detmar M. The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma. PLoS One 2012; 7: e49568; PMID: 23166713; http://dx.doi.org/10.1371/journal.pone.0049568
12. Xu N, Zhang L, Meisgen F, Harada M, Heilborn J, Homey B, Grandér D, Ståhle M, Sonkoly E. Pivarcsi A. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion. J Biol Chem 2012; 287: 29899-908; PMID: 22782903; http://dx.doi.org/10.1074/jbc.M112.391243
13. Jung YJ, Kim J W, Park SJ, Min BY, Jang ES, Kim NY, Jeong SH, Shin CM, Lee SH, Park YS, et al. c-Myc-mediated overexpression of miR-17-92 suppresses replication of hepatitis B virus in human hepatoma cells. J Med Virol 2013; 85: 969-78; PMID: 23532756; http://dx.doi.org/10.1002/jmv.23534
14. Li X, Zhang Z, Yu M, Li L, Du G, Xiao W, Yang H. Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2). Int J Mol Sci 2013; 14: 16226-39; PMID: 23924943; http://dx.doi.org/10.3390/ijms140816226
15. Chang Y, Liu C, Yang J, Liu G, Feng F, Tang J, Hu L, Li L, Jiang F, Chen C, et al. MiR-20a triggers metastasis of gallbladder carcinoma. J Hepatol 2013; 59: 518-27; PMID: 23665284; http://dx.doi.org/10.1016/j.jhep.2013.04.034
16. miR-20a facilitates metastasis of osteosarcoma cells to lung tissue. Bonekey Rep 2012; 1: 76; PMID: 23951469
17. Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M, Enokida H. Aberrant expression of microRNAs in bladder cancer. Nat Rev Urol 2013; 10: 396-404; PMID: 23712207; http://dx.doi.org/10.1038/nrurol.2013.113
18. Li X, Pan JH, Song B, Xiong EQ, Chen ZW, Zhou ZS, Su Y P. Suppression of CX43 expression by miR-20a in the progression of human prostate cancer. Cancer Biol Ther 2012; 13: 890-8; PMID: 22785209; http://dx.doi.org/10.4161/cbt.20841
19. Zhao S, Yao DS, Chen JY, Ding N. Aberrant expression of miR-20a and miR-203 in cervical cancer. Asian Pac J Cancer Prev 2013; 14: 2289-93; PMID: 23725129; http://dx.doi.org/10.7314/APJCp.2013.14.4.2289
20. Chang CC, Yang YJ, Li YJ, Chen ST, Lin BR, Wu TS, Lin SK, Kuo MY, Tan CT. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma. Oral Oncol 2013; 49: 923-31; PMID: 23602254; http://dx.doi.org/10.1016/j.oraloncology.2013.03.430
21. Fan MQ, Huang CB, Gu Y, Xiao Y, Sheng JX, Zhong L. Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. Journal of experimental & clinical cancer research. CR (East Lansing, Mich) 2013; 32: 21
22. Dong Q, Ji YS, Cai C, Chen ZY. LIM kinase 1 (LIMK1) interacts with tropomyosin-related kinase B (TrkB) and Mediates brain-derived neurotrophic factor (BDNF)-induced axonal elongation. J Biol Chem 2012; 287: 41720-31; PMID: 23086941; http://dx.doi.org/10.1074/jbc.M112.405415
23. Lindström NO, Neves C, McIntosh R, Miedzybrodzka Z, Vargesson N, Collinson JM. Tissue specific characterisation of Lim-kinase 1 expression during mouse embryogenesis. Gene Expr Patterns 2011; 11: 221-32; PMID: 21167960; http://dx.doi.org/10.1016/j.gep.2010.12.003
24. Estevez B, Stojanovic-Terpo A, Delaney MK, O'Brien KA, Berndt MC, Ruan C, Du X. LIM kinase-1 selectively promotes glycoprotein Ib-IX-mediated TXA2 synthesis, platelet activation, and thrombosis. Blood 2013; 121: 4586-94; PMID: 23620575; http://dx.doi.org/10.1182/blood-2012-12-470765
25. Nikitina EA, Medvedeva AV, Dolgaia IuF, Korochkin LI, Pavlova GV, Savvateeva-Popova EV. [Participation of GDNF, LIMK1 signal pathways and heat shock proteins in processes of Drosophila learning and memory formation]. Zh Evol Biokhim Fiziol 2012; 48: 588-96; PMID: 23401971
26. Li R, Doherty J, Antonipillai J, Chen S, Devlin M, Visser K, Baell J, Street I, Anderson RL, Bernard O. LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in mice. Clin Exp Metastasis 2013; 30: 483-95; PMID: 23239465; http://dx.doi.org/10.1007/s10585-012-9553-6
27. Zhang W, Gan N, Zhou J. Immunohistochemical investigation of the correlation between LIM kinase 1 expression and development and progression of human ovarian carcinoma. J Int Med Res 2012; 40: 1067-73; PMID: 22906279; http://dx.doi.org/10.1177/147323001204000325
28. Zhang H, Wang Y, Xing F, Wang J, Wang Y, Wang H, Yang Y, Gao Z. Overexpression of LIMK1 promotes migration ability of multidrug-resistant osteosarcoma cells. Oncol Res 2011; 19: 501-9; PMID: 22715593; http://dx.doi.org/10.3727/096504012X13286534482511
29. Roy P, Madan E, Kalra N, Nigam N, George J, Ray RS, Hans RK, Prasad S, Shukla Y. Resveratrol enhances ultraviolet B-induced cell death through nuclear factor-kappaB pathway in human epidermoid carcinoma A431 cells. Biochem Biophys Res Commun 2009; 384: 215-20; PMID: 19397895; http://dx.doi.org/10.1016/j.bbrc.2009.04.100
30. Prasad S, Madan E, Nigam N, Roy P, George J, Shukla Y. Induction of apoptosis by lupeol in human epidermoid carcinoma A431 cells through regulation of mitochondrial, Akt/PKB and NFkappaB signaling pathways. Cancer Biol Ther 2009; 8: 1632-9; PMID: 19625778; http://dx.doi.org/10.4161/cbt.8.17.9204
31. Ung N, Putoczki TL, Stylli SS, Ng I, Mariadason JM, Chan TA, Zhu HJ, Luwor RB. Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity. Cancer Biol Ther 2014; 15: 623-32; PMID: 24556630; http://dx.doi.org/10.4161/cbt.28179
32. Wu D, Guo Z, Min W, Zhou B, Li M, Li W, Luo D. Upregulation of TCTP expression in human skin squamous cell carcinoma increases tumor cell viability through anti-apoptotic action of the protein. Exp Ther Med 2012; 3: 437-42; PMID: 22969908
33. Xia YH, Li M, Fu DD, Xu SL, Li ZG, Liu D, Tian Z W. Effects of PTTG down-regulation on proliferation and metastasis of the SCL-1 cutaneous squamous cell carcinoma cell line. Asian Pac J Cancer Prev 2013; 14: 6245-8; PMID: 24377512; http://dx.doi.org/10.7314/APJCp.2013.14.11.6245
34. Sand M, Skrygan M, Georgas D, Sand D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma. J Dermatol Sci 2012; 68: 119-26; PMID: 23026055; http://dx.doi.org/10.1016/j.jdermsci.2012.09.004
35. Gastaldi C, Bertero T, Xu N, Bourget-Ponzio I, Lebrigand K, Fourre S, Popa A, Cardot-Leccia N, Meneguzzi G, Sonkoly E, et al. miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma. Carcinogenesis 2014; 35: 1110-20; PMID: 24374827; http://dx.doi.org/10.1093/carcin/bgt490
36. Bertero T, Bourget-Ponzio I, Puissant A, Loubat A, Mari B, Meneguzzi G, Auberger P, Barbry P, Ponzio G, Rezzonico R. Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties. Cell Cycle 2013; 12: 2183-93; PMID: 24067364; http://dx.doi.org/10.4161/cc.25330
37. Zhou M, Liu W, Ma S, Cao H, Peng X, Guo L, Zhou X, Zheng L, Guo L, Wan M, et al. A novel onco-miR-365 induces cutaneous squamous cell carcinoma. Carcinogenesis 2013; 34: 1653-9; PMID: 23514750; http://dx.doi.org/10.1093/carcin/bgt097
38. Olive V, Jiang I, He L. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 2010; 42: 1348-54; PMID: 20227518; http://dx.doi.org/10.1016/j.biocel.2010.03.004
39. Chen J, Yao D, Li Y, Chen H, He C, Ding N, Lu Y, Ou T, Zhao S, Li L, et al. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Int J Mol Med 2013; 32: 557-67; PMID: 23799609
40. Liu R, Liao J, Yang M, Shi Y, Peng Y, Wang Y, Pan E, Guo W, Pu Y, Yin L. Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans. J Toxicol Environ Health A 2012; 75: 1154-62; PMID: 22891887; http://dx.doi.org/10.1080/15287394.2012.699856
41. Scott RW, Hooper S, Crighton D, Li A, König I, Munro J, Trivier E, Wickman G, Morin P, Croft DR, et al. LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. J Cell Biol 2010; 191: 169-85; PMID: 20876278; http://dx.doi.org/10.1083/jcb.201002041
42. Jang I, Jeon BT, Jeong EA, Kim EJ, Kang D, Lee JS, Jeong BG, Kim JH, Choi BH, Lee JE, et al. Pak1/LIMK1/Cofilin Pathway Contributes to Tumor Migration and Invasion in Human Non-Small Cell Lung Carcinomas and Cell Lines. Korean J Physiol Pharmacol 2012; 16: 159-65; PMID: 22802696; http://dx.doi.org/10.4196/kjpp.2012.16.3.159